WHO approves use of experimental drugs

August 12, 2014 11:10 pm | Updated 11:10 pm IST - NEW DELHI:

The World Health Organisation (WHO) on Tuesday said that in the particular circumstances of the Ebola disease outbreak and provided certain conditions are met, it is ethical to offer unproven interventions as potential treatment or prevention.

The WHO convened a consultation on Monday to consider and assess the ethical implications for clinical decision-making of the potential use of unregistered interventions. The panel reached the consensus that ethical criteria must guide the provision of such interventions.

These include transparency about all aspects of care, informed consent, freedom of choice, confidentiality, respect for the person, preservation of dignity and involvement of the community, according to a statement.

The large number of people affected by the West Africa outbreak and the high fatality rate have prompted calls to use investigational medical interventions.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.